Influenza A Virus, H7N9 Subtype
"Influenza A Virus, H7N9 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 7 and neuraminidase 9. This avian origin virus was first identified in humans in 2013.
| Descriptor ID |
D064766
|
| MeSH Number(s) |
B04.820.545.405.400.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Influenza A Virus, H7N9 Subtype".
Below are MeSH descriptors whose meaning is more specific than "Influenza A Virus, H7N9 Subtype".
This graph shows the total number of publications written about "Influenza A Virus, H7N9 Subtype" by people in this website by year, and whether "Influenza A Virus, H7N9 Subtype" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza A Virus, H7N9 Subtype" by people in Profiles.
-
Emerging from the Shadow of Hemagglutinin: Neuraminidase Is an Important Target for Influenza Vaccination. Cell Host Microbe. 2019 12 11; 26(6):712-713.
-
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell Host Microbe. 2016 Jun 08; 19(6):800-13.
-
Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs. Influenza Other Respir Viruses. 2015 Sep; 9(5):263-70.
-
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains. J Clin Invest. 2015 Mar 02; 125(3):1255-68.
-
H7N9: preparing for the unexpected in influenza. Annu Rev Med. 2015; 66:361-71.
-
Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan. J Infect Dis. 2015 Jan 15; 211(2):249-57.
-
Divergent H7 immunogens offer protection from H7N9 virus challenge. J Virol. 2014 Apr; 88(8):3976-85.